Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Exercise/Conversion of 10,833 CTNM shares, $48.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 10,833 | $48.7K |
| Mar 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 3,611 | $16.2K |
| Jan 30, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 3,611 | $16.2K |
| Dec 30, 2025 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 3,611 | $16.2K |
| Apr 28, 2025 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 260,000 | n/a |